Cargando…
Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease
Individuals with mild cognitive impairment (MCI) are clinically heterogeneous, with different risks of progression to Alzheimer’s disease. Regular follow-up and examination may be time-consuming and costly, especially for MRI and PET. Therefore, it is necessary to identify a more precise MRI populat...
Autores principales: | Ge, Xiao-Yan, Cui, Kai, Liu, Long, Qin, Yao, Cui, Jing, Han, Hong-Juan, Luo, Yan-Hong, Yu, Hong-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413294/ https://www.ncbi.nlm.nih.gov/pubmed/34475445 http://dx.doi.org/10.1038/s41598-021-96914-3 |
Ejemplares similares
-
Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
por: Rui, Wenjuan, et al.
Publicado: (2021) -
Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021) -
Impact of cognitive reserve on the progression of mild cognitive impairment to Alzheimer's disease in Japan
por: Osone, Akira, et al.
Publicado: (2015) -
Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease
por: Liu-Seifert, Hong, et al.
Publicado: (2015) -
Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)